Verve Therapeutics

56 followers

‌

Verve Therapeutics is a biotechnology company focused on discovering and developing therapies that safely edit the genomes of adults to confer lifelong protection against coronary artery disease, the most common type of heart disease and the leading cause of death worldwide.

Employees

201-500

Links

Org chart

Hiring!

Sekar Kathiresan
Co-Founder & CEO

Sekar Kathiresan

Collapse
J. Keith Joung
Co-Founder
Barry Ticho
Co-Founder
Andrew Ashe
President & COO
Troy Lister
SVP, Research
Jeffrey Meltzer
VP, Quality
Yasser El-Gamal
VP, Legal Affairs & Chief Intellectual Property Counsel
Victoria Bartlett
VP, Program & Alliance Management
Joe Biedenkapp
VP, Editing Development
Victor Farutin
Senior Director, Computational Biology
Praveen Prasanna
Senior Director, External Manufacturing
Ann Dougherty
Senior Director, Medical Writing
Pratik Randeria
Director, Process Development
Stephen Johnson
Director, Patent Prosecution
William Toth
Director, Clinical Data Management
Mark Geng
Director, gRNA Process Development
Jill Wilson
Director, Human Resources Business Partner
Jessie Colgan
Director, External Manufacturing
Caitlin Moreno
Senior Manager, Environmental, Health & Safety
Leandro Alcantara
Senior Manager, IT Operations
Cody Suliveras-Jardine
Senior Sample Inventory Associate
Steve Briscoe
Senior Medical Writer
Carina Nyberg Washington
Senior Executive Assistant
Holly Beatrice
Senior Executive Assistant And HR Specialist
Alexandra Chadwick
Director, Editing & Discovery
Andrea Bartucca
Director, Patient Engagement, Enrollment, & Retention
Manashree Damle
Senior Scientist, Computational Biology
Katie Berth
Senior Manager, Technology Transfer & Process Engineering
Kayla Back
Senior Research Associate, Analytics
Matthew Schmidt
Senior Director, Regulatory Affairs
Emily Donlon
Director, Enterprise Applications